THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
THRX
Delisted
THRX was delisted on the 13th of February, 2024.
51 hedge funds and large institutions have $97.5M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
76% less capital invested
Capital invested by funds: $403M → $97.5M (-$305M)
Holders
51
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$2.71M | |
| 2 | +$819K | |
| 3 | +$791K | |
| 4 |
BlackRock
New York
|
+$788K |
| 5 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
+$678K |
Top Sellers
| 1 | -$8.78M | |
| 2 | -$2.07M | |
| 3 | -$1.29M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$632K |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$594K |